N, N., F, O., H, O., Y, N., & N, K. (2018). Design of a transdermal formulation containing raloxifene nanoparticles for osteoporosis treatment. Dove Medical Press.
Chicago Style (17th ed.) CitationN, Nagai, Ogata F, Otake H, Nakazawa Y, and Kawasaki N. Design of a Transdermal Formulation Containing Raloxifene Nanoparticles for Osteoporosis Treatment. Dove Medical Press, 2018.
MLA (8th ed.) CitationN, Nagai, et al. Design of a Transdermal Formulation Containing Raloxifene Nanoparticles for Osteoporosis Treatment. Dove Medical Press, 2018.
Warning: These citations may not always be 100% accurate.